Usana Health Sciences, Inc. (USNA) Tops Q1 EPS by 21c; Boosts FY12 Revs Outlook
Usana Health Sciences, Inc. (NYSE: USNA) reported Q1 EPS of $0.90, $0.21 better than the analyst estimate of $0.69. Revenue for the quarter came in at $154.1 million versus the consensus estimate of $145.33 million.
Usana Health Sciences, Inc. sees FY2012 EPS of $3.60-$3.70, versus the consensus of $3.44. Usana Health Sciences, Inc. sees FY2012 revenue of $610-$625 million, versus prior guidance of $600-$615 million and the consensus of $611 million.
For earnings history and earnings-related data on Usana Health Sciences, Inc. (USNA) click here.
Usana Health Sciences, Inc. sees FY2012 EPS of $3.60-$3.70, versus the consensus of $3.44. Usana Health Sciences, Inc. sees FY2012 revenue of $610-$625 million, versus prior guidance of $600-$615 million and the consensus of $611 million.
For earnings history and earnings-related data on Usana Health Sciences, Inc. (USNA) click here.